FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Ramucirumab 10 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Ramucirumab 10 mg/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Venetoclax 10 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Venetoclax 10 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Venetoclax 50 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Venetoclax 50 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Venetoclax 100 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Venetoclax 100 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely avelumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely avelumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely ivosidenib 250 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely ivosidenib 250 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely pembrolizumab 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely pembrolizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely pembrolizumab 25 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only radium-223 (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Radium-223 only product in parenteral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely teduglutide 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely teduglutide 5 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only midazolam in nasal dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only alpelisib (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Alpelisib only product in oral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Alpelisib 50 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Alpelisib 50 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely alpelisib 150 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely alpelisib 150 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely alpelisib 200 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely alpelisib 200 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing only polatuzumab vedotin (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Polatuzumab vedotin only product in parenteral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Bremelanotide only product Count of base of active ingredient False 1 Inferred relationship Some
    Bremelanotide only product in parenteral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only onabotulinumtoxinA (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    OnabotulinumtoxinA only product in parenteral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely onabotulinumtoxinA 200 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely onabotulinumtoxinA 200 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely onabotulinumtoxinA 100 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely onabotulinumtoxinA 100 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing only selinexor (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Selinexor only product in oral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Gadobutrol only product in oral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only nitrous oxide in pulmonary dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Glucagon only product in nasal dose form Count of base of active ingredient False 1 Inferred relationship Some
    Glucose 50 mg/mL and sodium chloride 9 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Glucose 50 mg/mL and sodium chloride 9 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 2
    Apremilast only product in oral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely apremilast 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely apremilast 20 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Apremilast 10 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Apremilast 10 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely apremilast 30 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely apremilast 30 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only darolutamide (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only darolutamide in oral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 270 microgram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely interferon alfa-2a (as peginterferon alfa-2a) 270 microgram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Interferon alfa-2a (as peginterferon alfa-2a) 360 microgram/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Interferon alfa-2b (as peginterferon alfa-2b) 100 microgram powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 120 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 80 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 150 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen Has presentation strength denominator value False 1 Inferred relationship Some 1
    Interferon alfa-2b (as peginterferon alfa-2b) 120 microgram powder for solution for injection pen Count of base of active ingredient False 1 Inferred relationship Some
    Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen Has presentation strength denominator value False 1 Inferred relationship Some 1
    Interferon alfa-2b (as peginterferon alfa-2b) 150 microgram powder for solution for injection pen Count of base of active ingredient False 1 Inferred relationship Some
    Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen Count of base of active ingredient False 1 Inferred relationship Some
    Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection pen Has presentation strength denominator value False 1 Inferred relationship Some 1
    Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen Count of base of active ingredient False 1 Inferred relationship Some
    Interferon alfa-2b (as peginterferon alfa-2b) 80 microgram powder for solution for injection pen Has presentation strength denominator value False 1 Inferred relationship Some 1
    Pexidartinib only product Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only pexidartinib in oral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely albumin human 250 milligram/1 milliliter conventional release solution for infusion (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely albumin human 250 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing only albumin human (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Albumin human only product in parenteral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Albumin human 50 mg/mL solution for infusion Has concentration strength denominator value False 1 Inferred relationship Some 1
    Albumin human 50 mg/mL solution for infusion Count of base of active ingredient False 1 Inferred relationship Some
    Albumin human 45 mg/mL solution for infusion Count of base of active ingredient False 1 Inferred relationship Some
    Albumin human 45 mg/mL solution for infusion Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely albumin human 200 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely albumin human 200 milligram/1 milliliter conventional release solution for infusion (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Pretomanid only product Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only pretomanid in oral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely crisantaspase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely crisantaspase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Pitolisant only product Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only pitolisant in oral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only entrectinib (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only entrectinib in oral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Fedratinib only product Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only fedratinib in oral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Tegaserod only product in oral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only liraglutide in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some

    Start Previous Page 206 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start